Germline PAX5 mutation predisposes to familial B-cell precursor acute lymphoblastic leukemia

Blood. 2021 Mar 11;137(10):1424-1428. doi: 10.1182/blood.2020005756.

Nicolas Duployez^{1

2}, Laura A Jamrog³, Vincent Fregona³, Camille Hamelle³, Laurène Fenwarth^{1

2}, Sophie Lejeune⁴, Nathalie Helevaut^{1

2}, Sandrine Geffroy^{1

2}, Aurélie Caillault^{1

2}, Alice Marceau-Renaut^{1

2}, Stéphanie Poulain^{1

2}, Catherine Roche-Lestienne^{2

5}, Laetitia Largeaud^{3

6}, Naïs Prade^{3

6}, Stéphanie Dufrechou^{3

6}, Sylvie Hébrard³, Céline Berthon^{2

7}, Brigitte Nelken⁸, José Fernandes⁹, Céline Villenet¹⁰, Martin Figeac¹⁰, Bastien Gerby³, Eric Delabesse^{3

6}, Claude Preudhomme^{1

2}, Cyril Broccardo³

¹ Laboratory of Hematology, Biology and Pathology Center, Centre Hospitalier Universitaire (CHU) Lille, Lille, France.
² INSERM, U1277, Lille, France.
³ Centre de Recherches en Cancérologie de Toulouse, INSERM UMR-1037, Université de Toulouse III Paul Sabatier, Toulouse, France.
⁴ Department of Clinical Genetics and.
⁵ Institute of Medical Genetics, Jeanne de Flandre Hospital, CHU Lille, Lille, France.
⁶ Department of Hematology, CHU Toulouse, Toulouse, France.
⁷ Department of Clinical Hematology, Claude Huriez Hospital, and.
⁸ Department of Pediatric Hematology, Jeanne de Flandre Hospital, CHU Lille, Lille, France.
⁹ Department of Clinical Hematology, Centre Hospitalier Valenciennes, Valenciennes, France; and.
¹⁰ Université de Lille, Functional Genomics Platform, Lille, France.

No abstract available

Publication types